Indian National Drug Company Private Limited, a active private limited company, was established on 24 July 1944 in Kolkata, West Bengal, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24232WB1944PTC011807. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.20 M.
It upholds a compliant status. Its leadership includes Soumya Roy Chowdhury (Director), Sreemoyee Roychowdhury (Director), Malay Roychowdhury (Director). Past directors included Soumya Roy Chowdhury, Sanchalika Bhattacharya. It holds ₹5.06 Cr open charges and ₹9.22 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5/2 Dr S C Banerjee Road, Kolkata, West Bengal, 700085.
U24232WB1944PTC011807
011807
24 July 1944
₹1.50 M
₹1.20 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Indian National Drug Company Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Soumya Roy Chowdhury | Director | 01 Apr 2021 | Current |
| Sreemoyee Roychowdhury | Director | 16 Jun 2010 | Current |
| Malay Roychowdhury | Director | 01 Apr 1988 | Current |
| Simantika Roychowdhury | Director | 03 May 1984 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Manager | 01 Apr 2021 | Past |
| Pramod Abcsdd | Director | 07 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indian National Drugs Co Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.82% decrease. The company also saw a substantial fall in profitability, with a 12.33% decrease in profit. The company's net worth Soared by an impressive increase of 13.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Indian National Drug Company had a public holding of 1.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,591,999.00
₹92,180,111.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2015 | Pnb Housing Finance Limited | ₹5.06 Cr | Satisfied |
| 30 Jul 2014 | Hdb Financial Services Limited | ₹3.61 Cr | Satisfied |
| 07 Jul 2006 | State Bank Of India | ₹3.00 M | Satisfied |
| 07 Oct 2002 | State Bank Of India | ₹2.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Indian National Drug Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indian National Drug Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indian National Drug Company's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Indian National Drug Company Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
Indian National Drug Company Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was recorded as a recent event.
The activity A charge registered on 30 Jan 2015 via Charge ID 10567642 with Pnb Housing Finance Limited was fully satisfied on 19 Mar 2025. was completed.
The activity Soumya Roy Chowdhury was appointed as a Director was appointed as a Director on 01 Apr 2021 & has been associated with this company since 4 years 8 months . was completed.
A charge registered on 07 Jul 2006 via Charge ID 80041023 with State Bank Of India was fully satisfied on 22 Jun 2015. was recorded as a recent event.
A charge registered on 30 Jul 2014 via Charge ID 10511842 with Hdb Financial Services Limited was fully satisfied on 21 May 2015. was recorded as a recent event.
The CIN of Indian National Drug Company Private Limited is U24232WB1944PTC011807.
Indian National Drug Company Private Limited is headquartered at 5/2 Dr S C Banerjee Road, Kolkata, West Bengal, 700085.
Indian National Drug Company Private Limited was incorporated on 24 July 1944.
The current directors of Indian National Drug Company Private Limited are
The primary industry of Indian National Drug Company Private Limited is Manufacturing.
Indian National Drug Company Private Limited is unlisted.
The authorized capital of Indian National Drug Company Private Limited is ₹1.50 M, and the paid-up capital is ₹1.20 M.
The compliance status of Indian National Drug Company Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX